In July, Oman's Ministry of Commerce, Industry and Investment Promotion put four healthcare projects on the market, worth about RO 16 million combined. The announcement came with a promise investors love to hear: these opportunities are built on actual market needs.
I believe the ministry means it. I've sat across the table from people in these ministries, and the intent is real.
But "the government identified a need" and "this project will make money for you" are two different sentences. The gap between them is where most market entries go wrong.
So let's do what a careful buyer does. Look at what's actually on offer, then run each project through the four questions that decide whether a healthcare investment in Oman works. Spoiler: the answer isn't in the feasibility study. It's in who pays, who staffs, who refers, and how you're structured.
What's actually on the table
The package was built through the Invest in Oman platform with the Ministry of Health and the free zones authority. Two projects deliver care. Two make supplies.
| Project | Location | Estimated Investment |
|---|---|---|
| Early detection center (screening, early diagnosis, preventive medicine | Bausher, Muscat | RO 7.5 million |
| Specialized rehabilitation hospital | Muscat Governorate | RO 6 million |
| Chlorhexidine gluconate solution manufacturing | Salalah Free Zone | RO 2.4 million |
| Paraffin-embedded gauze manufacturing | Sohar Free Zone | RO 577,500 |
Notice the split. The care projects make up about 82% of the money and carry most of the operating risk. The manufacturing projects are smaller and sit in free zones, which changes the ownership and incentive picture entirely.
These are four different businesses with four different risk profiles. Treating them as one "Oman healthcare opportunity" is the first mistake I'd ask you not to make.
Oman is a selective market, and that's the point
If you came to the Gulf chasing scale, Saudi Arabia is where scale lives. Oman is different. Analysts covering the region describe it as a market of targeted plays tied to specific service gaps, not a land grab.
The numbers back that up. Oman's private health sector runs 36 hospitals and more than 2,300 institutions, handling over 4 million visits a year with about 22,600 staff. Meanwhile the Ministry of Health runs 56 hospitals of its own and is still building. The public system is large, free for Omanis, and expanding.
That tells you something important. In Oman, you are rarely competing with the government. You are filling a specific hole the government has decided it would rather not fill itself. When you pick the right hole, a small market works in your favor: fewer competitors, closer relationships, and a ministry that actively wants you to succeed.
When you pick the wrong one, there's no volume to bail you out.
The four questions that decide whether it pencils out
A feasibility study tells you demand exists. These four questions tell you whether that demand turns into revenue you can actually collect.
1. Who pays, and are they on record?
This is where I'd start, because it's where I've spent years of my career: at the desk where a service either gets paid or doesn't.
Oman's mandatory employer-funded insurance scheme, Dhamani, is expanding private-sector coverage. But the basic policy is built around inpatient care, emergencies, basic illnesses, and prescribed drugs. Preventive screening isn't the centerpiece of that mandate.
So for the early detection center, ask hard questions. Is the volume coming from insurers who cover screening above the basic plan? Corporate wellness contracts? Self-pay patients? A ministry contract that pays for outcomes? Each answer produces a very different business.
The rehabilitation hospital has the same problem in a different shape. Rehab means long stays and long courses of therapy. Find out early which payers will fund an 8-week inpatient program, and at what rate.
Ask before you bid: Which payers have committed, in writing, to cover this service line, and at what reimbursement?
2. Who staffs it?
Oman's investment authority estimates the country needs about 13,000 more medical professionals by 2040. Rehabilitation is staffing-heavy: physiotherapists, occupational therapists, speech therapists and rehab nurses, all in short supply across the Gulf.
Add Omanisation targets on top, and your staffing plan becomes your business plan. If the model only works with an all-expat team at today's salaries, it won't work for long.
Ask before you bid: What Omanisation ratio applies to this facility, and is there a training pipeline I can plug into or build?
3. Who refers patients to you?
A screening centre lives or dies on what happens after a positive result. Where does that patient go next? If there's no agreed pathway into diagnostics and treatment, you're selling bad news with no follow-through. Patients notice, and so do referring doctors.
Rehab is even more dependent on referrals. Most acute care in Oman happens in Ministry of Health hospitals, so your patient flow depends on discharge agreements with the public system. Oman's national electronic health record, Al Shifa, already links more than 200 facilities across public and private care. Know how your facility connects to it before you open.
Ask before you bid: Which hospitals will refer to us, under what agreement, and how will our records connect?
4. How are you structured, and who's the anchor buyer?
This question matters most for the two manufacturing projects. Both sit in free zones, which offer 100% foreign ownership and subsidized land leases. That's a real advantage.
But a factory needs a customer. The ministry frames these projects around replacing imports and selling into regional markets. Both are fair goals, and neither is a purchase order. At RO 577,500, the gauze plant is small enough that one anchor contract could make or break it.
Ask before you bid: Is there a procurement preference or offtake commitment for locally made supplies, and who signs it?
The most expensive mistake in healthcare market entry
I say this often because I keep watching it happen: the most expensive mistake in healthcare market entry is a solution nobody asked for.
Now, you might think a government-backed package protects you from that. The ministry did the study. The need is documented. What could go wrong?
Here's the catch. The government asked for the service. That doesn't mean a payer asked to fund it at your price, a hospital asked to refer to you, or a workforce exists to run it on your timeline. "Needed" and "funded, staffed and referred" are not the same thing, and the space between them is where capital goes to die.
The investors who win in Oman treat a ministry package as a starting hypothesis, not a finished thesis. They spend a few weeks and a modest budget validating the four questions above before they spend millions building. That isn't caution for its own sake. It's the cheapest insurance you'll ever buy.
Quick answers to the questions I get most
Can a foreign investor own a healthcare business in Oman? In most cases, yes. Oman's Foreign Capital Investment Law (Royal Decree 50/2019) took effect in January 2020 and allows 100% foreign ownership outside a short negative list of reserved activities. Free zones also allow full foreign ownership. Ownership is only half the story, though. Every healthcare facility still needs a technical and operational license from the Ministry of Health, and some care-related activities carry their own restrictions. Confirm your specific activity with Omani counsel before you commit capital.
What incentives come with healthcare projects? Invest Oman points to subsidized land leases for healthcare projects and full foreign ownership in free zones. The bigger incentive is less visible: a ministry that put these projects on the market wants them to succeed. That relationship is worth more than any lease discount, if you build it properly.
Is Oman a better bet than the UAE? A different bet, not better or worse. The UAE, and Dubai in particular, is the crowded, well-signposted gateway with deep free-zone infrastructure. Oman is smaller and quieter, with fewer competitors and closer access to decision-makers. If your model needs volume, start in the UAE or Saudi Arabia. If it fills a specific gap the government has named, Oman can be the easier place to win.
How long does it take to validate one of these opportunities? A focused validation of payer, staffing, referral, and structure questions typically takes weeks, not months. It costs a fraction of what you'd lose by skipping it.
The bottom line
Oman's RO 16 million package is a genuine signal. The ministry has named what it wants built and invited private capital to build it. That's more clarity than most markets ever give you.
But a signal isn't a business case. Run every project through four questions: who pays, who staffs, who refers, and who buys. The ones that survive are worth your money. The ones that don't just save you a lot of it.
If you're weighing one of these projects, or any healthcare move into Oman, start with the Oman Healthcare Opportunity Alignment Map. It lays out where national priorities and real commercial demand actually overlap. Or book a conversation, and we'll pressure-test your thesis together.
SMT Strategies Global provides advisory and execution for healthcare investors and operators entering Oman, the wider GCC and Central Africa. We help you find out what the market wants before you build it.
Sources
Oman offers RO 16 million healthcare projects, Oman Observer, July 11, 2026
GCC healthcare investment opportunities in 2026, Licorne Gulf
Health sector growth accelerates as Oman boosts self-sufficiency, Muscat Daily, April 2026
Oman rolls out mandatory health insurance scheme, Mercer
Healthcare sector overview, Invest Oman
The health and wellness economy: Oman's new growth engine, Oman Observer
Starting a business in Oman as a foreigner, Emerhub
The new Foreign Capital Investment Law in Oman, BSA Law